Post-thyroid FNA testing and treatment options: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference


  • The following medical societies are co-sponsors of the NCI Thyroid Fine Needle Aspiration State of the Science Conference and Website: The American Cancer Society, College of American Pathologists, The American Society for Clinical Pathology, The American Society of Clinical Oncology, La Societe Francaise de Cytologie Clinique, The American Society of Cytopathology, The Papanicoloau Society of Cytopathology, The American Association of Clinical Endocrinologists, The American Association of Endocrine Surgeons, The American Thyroid Association, The Society of Radiologists in Ultrasound, The American College of Radiology, National Comprehensive Cancer Network, The American College of Endocrinology.

  • This article is a US Government Work and, as such, is in the public domain in the United States of America.


The National Cancer Institute (NCI) sponsored the NCI Thyroid Fine Needle Aspiration (FNA) State of the Science Conference on October 22–23, 2007 in Bethesda, MD. The 2-day meeting was accompanied by a permanent informational Web site and several on-line discussion periods between May 1 and December 15, 2007 ( This document addresses follow-up procedures and therapeutic options for suggested diagnostic categories. Follow-up options for “nondiagnostic” and “benign” thyroid aspirates are given. The value of ultrasound examination in the follow-up of “nondiagnostic” and “benign” thyroid aspirates is discussed. Ultrasound findings requiring reaspiration or surgical resection are described as are the timing and length of clinical and ultrasonographic surveillance for cytologically “benign” nodules. Options for surgical intervention are given for the diagnostic categories of “atypical/borderline,” “follicular neoplasm,” “suspicious for malignancy” and “malignant” ( Diagn. Cytopathol. 2008;36:442–448. © 2008 Wiley-Liss, Inc.